Reply  by Mastracci, Tara M. et al.
Larzon et al,6 an exact method was used to estimate multivariate
logistic regression analysis of mortality in relation to circulatory
shock, age 76 years, loss of consciousness, hemoglobin 90
g/L, creatinine 190 mol/L, and electrocardiographically
documented ischemia. In the randomized controlled trial by
Hinchliffe et al,7 patient characteristics in the two treatment
arms were similar. Pooled analysis of the adjusted ORs from the
four observational studies and the OR from the randomized
controlled trial (representing 6097 patients: 389 in the endo-
vascular repair group and 5708 in the open repair group)
demonstrated a statistically nonsignificant 29% reduction in
mortality with endovascular relative to open repair in a random-
effects model (OR, 0.71; 95% confidence interval, 0.41 to 1.22;
P  .21) (Fig). There was neither between-study heterogeneity
of results analyzed by means of standard 2 tests (P  .21) nor
evidence of significant publication bias assessed mathematically
using an adjusted rank-correlation test (P  .33).
Despite the conclusions by Mastracci et al,1 the present meta-
analysis pooling adjusted ORs failed to demonstrate statistically
significant benefit of endovascular over open repair for mortality in
ruptured abdominal aortic aneurysms.
Hisato Takagi, MD, PhD
Norikazu Kawai, MD
Takuya Umemoto, MD, PhD
Department of Cardiovascular Surgery
Shizuoka Medical Center
Shizuoka, Japan
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Reply
Thank you for the opportunity to respond to the letter from
Dr Takagi and colleagues. Dr Takagi and colleagues write that we
“concluded that mortality in patients undergoing endovascular
repair of ruptured abdominal aortic aneurysms was lower than that
in historical reports of unselected patients undergoing open re-
pair.” Though this is an accurate report of the data, it does not
accurately represent our conclusions, which take into account the
strength of the evidence and the possibility that other confounding
factors – most importantly, patient selection – might have led to
the observed findings.1 In the discussion, we wrote “it is not
possible to conclude that the results in patients treated with
REVAR are better than those for open surgery” and in the abstract
“Mortality in people who underwent REVAR is lower than that in
historical reports of unselected people undergoing open repair.
Further investigation is needed to determine whether the differ-
ence in mortality is attributable to patient selection alone or to this
new approach to treatment.” Clear inferences about relative effi-
cacy cannot be drawn from our work, and we said as much.
We made an a priori decision to analyze the data in the manner
reported: that is, to include only the treatment arms. We hypoth-
esized (correctly, as it turned out) that the composition of com-
parison groups would be highly variable between studies.
Dr Takagi and colleagues briefly report an alternative ap-
proach to the problem of summarizing data from observational
studies. They included only studies which reported adjusted odds
ratios for mortality comparing REVAR with open surgery. Likely
because of the brevity of the current format, they do not report the
composition of the group undergoing open repair in the case of the
observational studies, which we regard as critical. The factors
controlled for in statistical analysis differ between the four obser-
vational studies, and do not include the presence of circulatory
shock in one of the four. These adjusted odds ratios have been
combined with the unadjusted odds ratio from the single random-
ized controlled trial in this area. Though there are obvious limita-
tions to this approach (as there are to our own), it is not unreason-
able, and we would encourage Takagi and colleagues to present a
complete version of their research synthesis for peer review and
publication. As presented here, our interpretation of their data (a
statistically nonsignificant benefit from endovascular technique:
odds ratio 0.71; 95% confidence interval, 0.41 to 1.22; P  .21)
does not change our conclusions. As we wrote of our own findings,
“this work offers support for this technique in patients in centers
Fig. Forest plot of adjusted odds ratios of included studies.
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where adequate expertise and resources are available without in-
curring delay.” Our further recommendations for future work, that
a large multicenter randomized controlled trial be performed and
that centers performing endovascular repair of ruptured aneurysms
contribute to a central registry, are also unchanged.
Tara M. Mastracci, MD
Luis Garrido-Olivares, MD
Claudio S. Cina, MD, Spec Chir(lt), FRCS(c), MSc, a
Catherine M. Clase, MB, Bchir, MSc, FRCP(c)
McMaster University
Department of Medicine
Hamilton, Ontario, Canada
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Regarding “Informed consent for AAA repair:
Assessing variations in surgeon opinion through a
national survey”
Berman et al1 are to be commended for seeking “to define
national surgeon opinion regarding the content of informed con-
sent discussions” for AAA repair, but leave out an important
aspect. Although they cite the two randomized trials demonstrat-
ing no benefit from repair of AAA smaller than 5.5 cm in diameter
and note that the legal definition of informed consent “includes
discussion of the risks, benefits, and alternatives to an interven-
tion”, they neglect to ask in their survey whether the surgeon
discussed the trial results with patients who have AAA smaller than
5.5 cm. If patients with AAA substantially below this threshold are
told that they “need” AAA repair and subsequently suffer an
adverse outcome, preoperative review of the surgical risks without
discussion of whether repair was indicated may not be considered
sufficient.
Frank A. Lederle, MD
Minneapolis VA Center for Epidemiological and Clinical
Research (CECR)
Minneapolis, Minn
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Reply
We agree that discussion of whether repair is indicated is an
essential component of informed consent not only for patients
with smaller aneurysms but for all patients considering AAA repair.
This falls under the category of discussion of “alternatives to
intervention”, the alternative in this case being no intervention at
all. In our survey, 97% of respondents stated that it was essential to
discuss outcomes related to nonintervention during informed con-
sent. (We did not discuss these findings due to space limitations.)
We did not ask specifically about informed consent practices with
patients with aneurysms 5.5 cm, but we believe that it is impor-
tant in all cases to present the data and help each individual patient
arrive at the treatment decision that is best for them rather than
telling anyone that they “need” an aneurysm repair.
Loren Berman, MD
Alan Dardik, MD, PhD
Richard Gusberg, MD
Liana Fraenkel, MD, MPH
Yale University School of Medicine
New Haven, Conn
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Regarding “Endovascular vs open repair of acute
abdominal aortic aneurysms–A systematic review and
meta-analysis”
The recent meta-analysis comparing endovascular with open
repair of acute (ruptured or symptomatic intact) abdominal aortic
aneurysms (AAAs) supports a considerable benefit of endovascular
aneurysm repair (EVAR) procedures.1 Compared with open re-
pair, EVAR was associated with a significant 38% reduction in
mortality (pooled odds ratio, 0.624; 95% confidence interval [CI],
0.518 to 0.752; P  .0001), a shorter intensive care unit (pooled
effect size estimate, 0.70 days; 95% CI, 1.05 to 0.35 days;
P  .0001), and hospital stay (pooled effect size estimate, 0.33
days; 95% CI, 0.50 to 0.16 days; P  .0001), as well as a
significant reduction in blood loss (pooled effect size estimate,
1.88 lt; 95% CI, 2.49 to 1.27 lt; P  .0001) and procedure
time (pooled effect size estimate, 0.65 hours; 95% CI, 0.95 to
0.36 hours; P  .0001).1
In two of the five parameters examined in the meta-analysis,
there was evidence of both heterogeneity and bias, that is, in
intensive care unit stay (heterogeneity: Cochran Q test, 46.57; P
.0001; bias: Egger test, 3.98; P  .0085), and operative blood
loss (heterogeneity: Cochran Q test, 51.91; P .0001; bias: Egger
test, 4.94; P  .0032).1 In another two parameters, there was
evidence of either heterogeneity or bias, ie, in mortality (hetero-
geneity: Cochran Q test, 15.449; P  .750; bias: Egger test,
0.649; P .017) and procedure duration (heterogeneity: Coch-
ran Q test, 30.82; P  .0012; bias: Egger test, 0.34; P  .82).1
The only parameter showing neither significant heterogeneity nor
bias was the length of postoperative stay.1
Additionally, in all the trials evaluated in the meta-analysis, the
inclusion criteria for study entry were: (1) adequate hemodynamic
stability for patients to undergo a preoperative CT scan, (2) AAA
anatomical suitability for EVAR (eg, appropriate proximal neck
length), and/or (3) the presence of sufficient personnel for the
performance of EVAR. When these inclusion criteria were not met,
the patient was either excluded from the study or an emergency
open AAA repair was performed.
Another drawback that questions the validity of the results of
this meta-analysis is that only one of the 23 studies included was a
randomized controlled trial between EVAR and open repair for
ruptured AAAs;2 however, this study also had several exclusion
criteria.2
Based on the specificity of the selection/inclusion criteria, as
well as the reported heterogeneity and associated bias of the
reported results, it may be premature for any definite conclusions
to be drawn. EVAR may be a reasonable option for symptomatic
(but intact) AAAs; however, in true emergency AAAs (as in the case
of ruptured AAAs), patients may not be hemodynamically stable
for a preoperative evaluation CT scan of the AAA anatomy to be
performed. There may also be ethical limitations in designing
appropriate randomized controlled trials to provide definitive
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